Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response
Journal of Allergy and Clinical Immunology · 2024-09 · 154 (3) · 807-818
DOI: 10.1016/j.jaci.2024.04.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024-09. Verfasst von Jelle M Blankestijn und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Infection and Immunity,…. Hauptthemen laut MEDLINE: COVID-19, Transcriptome, SARS-CoV-2, Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis, Health~Holland.
Abstract (Originalsprache)
BACKGROUND: Months after infection with severe acute respiratory syndrome coronavirus 2, at least 10% of patients still experience complaints. Long-COVID (coronavirus disease 2019) is a heterogeneous disease, and clustering efforts revealed multiple phenotypes on a clinical level. However, the molecular pathways underlying long-COVID phenotypes are still poorly understood. OBJECTIVES: We sought to cluster patients according to their blood transcriptomes and uncover the pathways underlying their disease. METHODS: Blood was collected from 77 patients with long-COVID from the Precision Medicine for more Oxygen (P4O2) COVID-19 study. Unsupervised hierarchical clustering was performed on the whole blood transcriptome. These clusters were analyzed for differences in clinical features, pulmonary function tests, and gene ontology term enrichment. RESULTS: Clustering revealed 2 distinct clusters on a transcriptome level. Compared with cluster 2 (n = 65), patients in cluster 1 (n = 12) showed a higher rate of preexisting cardiovascular disease (58% vs 22%), higher prevalence of gastrointestinal symptoms (58% vs 29%), shorter hospital duration during severe acute respiratory syndrome coronavirus 2 infection (median, 3 vs 8 days), lower FEV1/forced vital capacity (72% vs 81%), and lower diffusion capacity of the lung for carbon monoxide (68% vs 85% predicted). Gene ontology term enrichment analysis revealed upregulation of genes involved in the antiviral innate immune response in cluster 1, whereas genes involved with the adaptive immune response were upregulated in cluster 2. CONCLUSIONS: This study provides a start in uncovering the pathophysiological mechanisms underlying long-COVID. Further research is required to unravel why the immune response is different in these clusters, and to identify potential therapeutic targets to create an optimized treatment or monitoring strategy for the individual long-COVID patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands; Amsterdam Public Health, Amsterdam, The N…
- Department of Health, Ortec B.V., Zoetermeer, The Netherlands.
- Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.
- School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Department of Internal Medicine, VieCuri Medical Center, V…
- Experimental Immunology (EXIM), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Experimental Immunology (EXIM), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Förderung
- Novartis
- Health~Holland
Zitieren
APA
Blankestijn, J. M., Baalbaki, N., Bazdar, S., Beekers, I., Beijers, R. J. H. C. G., van den Bergh, J. P., Bloemsma, L. D., Cornelissen, M. E. B., Dekker, T., Duitman, J. W., Houweling, L., Jacobs, J. J. L., van der Lee, I., Linders, P. M. A., Noij, L. C. E., Nossent, E. J., van de Pol, M. A., Sondermeijer, B. M., Geelhoed, J. J. M., …, & P4O2 Consortium (2024). Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response. Journal of Allergy and Clinical Immunology, 154(3), 807-818. https://doi.org/10.1016/j.jaci.2024.04.032
Vancouver
Blankestijn JM, Baalbaki N, Bazdar S, Beekers I, Beijers RJHCG, van den Bergh JP, et al. Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response. Journal of Allergy and Clinical Immunology. 2024;154(3):807-818. doi:10.1016/j.jaci.2024.04.032
BibTeX
@article{Blankestijn2024,
author = {Blankestijn, Jelle M and Baalbaki, Nadia and Bazdar, Somayeh and Beekers, Inés and Beijers, Rosanne J H C G and van den Bergh, Joop P and Bloemsma, Lizan D and Cornelissen, Merel E B and Dekker, Tamara and Duitman, Jan Willem and Houweling, Laura and Jacobs, John J L and van der Lee, Ivo and Linders, Paulien M A and Noij, Lieke C E and Nossent, Esther J and van de Pol, Marianne A and Sondermeijer, Brigitte M and Geelhoed, J J Miranda and Weersink, Els J M and Golebski, Korneliusz and Abdel-Aziz, Mahmoud I and Maitland-van der Zee, Anke H and P4O2 Consortium, P4O2 Consortium},
title = {Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
volume = {154},
number = {3},
pages = {807--818},
doi = {10.1016/j.jaci.2024.04.032}
}
EUVIMED